1. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: The ADVANCE CRT-D Trial
- Author
-
Gasparini, M, Anselme, F, Clementy, J, Santini, M, Martínez-Ferrer, J, De Santo, T, Santi, E, Schwab, Jo, F, Ricci, R, Kloppe, A, Lunati, M, Proclemer, A, Molon, G, Delache, B, Poschmann, G, Vincenti, A, Hügl, B, Babuty, D, Martinez Ferrer, J, Alzueta Rodriguez, J, Mabo, P, Tritto, M, Bocchiardo, M, Senatore, G, Peinado, R, Tercedor, L, Davy, Jm, Elbaz, N, Glikson, M, Libero, L, Adornato, F, Mantovan, R, Pasquie, Jl, Lavergne, T, Curnis, A, Valle Tudela, V, Schäfer, J, Occhetta, E, Marzegalli, M, Cappato, R, Arenal, A, Barnay, C, Camous, Jp, Durand, P, Mermi, J, Aharon Glick SV, Solimene, F, Botto, G, Ivaldi, M, Zecchi, P, de Sousa AE, Betts, T, Bru, P, Dinanian, S, Deharo, Jc, Leenhardt, A, Sbragia, P, Da Costa, A, Geist, M, Calvi, V, Zardini, M, Orland, M, Ledesma Garcia, J, Martinez, J, Mainardis, M, Cantù, F, Leclercq, Jf, García Robles JA, Wiezcorek, M, Brambilla, R, Hennersdorf, M, Pignalberi, C, Ruiz, A, Rebellato, L, Pedrinazzi, C, Kajackas, A, Burrone, V, Martin, E, Farges, E, Silveira, J, and Pepe, M.
- Subjects
Male ,Tachycardia ,medicine.medical_specialty ,Heart Ventricles ,medicine.medical_treatment ,Population ,Electric Countershock ,Cardiac resynchronization therapy ,Ventricular tachycardia ,Disease-Free Survival ,Electrocardiography ,Internal medicine ,Humans ,Medicine ,Single-Blind Method ,Prospective Studies ,education ,Aged ,education.field_of_study ,Presyncope ,medicine.diagnostic_test ,business.industry ,Cardiac Pacing, Artificial ,medicine.disease ,Defibrillators, Implantable ,Survival Rate ,Treatment Outcome ,Anesthesia ,Ventricular fibrillation ,Tachycardia, Ventricular ,Antitachycardia Pacing ,Cardiology ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Background This multicenter, prospective, randomized, controlled, parallel trial compares the efficacy of biventricular (BIV) versus right ventricular (RV) antitachycardia pacing (ATP) in terminating all kinds of ventricular tachycardia (VT). Methods Five hundred twenty-six patients implanted with a cardiac resynchronization therapy defibrillator (CRT-D) device were enrolled and randomized 1:1 to either BIV (266) or RV (260) ATP (single burst 8 pulse, 88% coupling interval) and were followed up for 12 months. Results During 12 months' follow-up, 1,077 ventricular episodes in 180 patients were detected and classified: 634 true VTs divided into 69 ventricular fibrillation (VF) (11%), 202 fast ventricular tachycardia (FVT) (32%), and 363 VT (57%). A comparable first ATP efficacy (BIV 65% vs RV 68%, P = .59) was observed in FVT + VT, in VT zone (BIV 62% vs RV 71%, P = .25), and in FVT zone (BIV 71% vs RV 61%, P = .34). A trend toward lower accelerations during ATP applied to FVT was observed in the BIV group (3.5% BIV vs 10.2% RV, P = .163). No syncope/presyncope occurred during ATP for FVT in the BIV group versus 4 events (3.2%) in the RV group ( P = .016). biventricular ATP was more effective in treating FVT in coronary artery disease (CAD) patients ( P = .032), whereas both modalities presented similar efficacy in patients with non-CAD etiology ( P = .549). Conclusions Antitachycardia pacing is effective in patients implanted with a CRT-D device. No significant differences in efficacy emerged between BIV- and RV-delivered ATP in the general population, whereas BIV ATP seems to present a safer profile in ischemic patients.
- Published
- 2010